Results 221 to 230 of about 6,549,758 (385)

Evidence-based Laboratory Medicine: Supporting Decision-Making [PDF]

, 2000
Christopher P. Price
openalex   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Evidence-Based Medicine Within Surgical Practice and Training: A Scoping Review. [PDF]

World J Surg
Tokidis E, Perin G, Vivekananda-Schmidt P, Balasubramanian SP.   +3 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Evidence-based medicine during the COVID-19 pandemic: A hematologist's perspective. [PDF]

Hematol Transfus Cell Ther
Gonzaga Y.
europepmc   +1 more source

ChatGPT fails the test of evidence-based medicine. [PDF]

Eur Heart J Digit Health, 2023
Haverkamp W, Tennenbaum J, Strodthoff N.
europepmc   +1 more source

Alternative Therapies and Medical Science: Designing Clinical Trials of Alternative/Complementary Medicines—Is Evidence‐Based Traditional Chinese Medicine Attainable? [PDF]

, 2000
Julia Critchley, Zhang Ye, Chuthamanee Suthisisang, Thomas Y. K. Chan, Brian Tomlinson   +4 more
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Adoption of evidence-based medicine: A comparative study of hospital and community pharmacists in Saudi Arabia. [PDF]

PLoS One
Alzahrani F, Almutairi N, Aloufi A, Kattan A, Hakeem A, Alharbi M, Alarawi N, Fadil HA, Habeeb E.   +8 more
europepmc   +1 more source

Towards evidence-based medicine for paediatricians [PDF]

, 2017
Phillips, Bob
core   +2 more sources